Belotecan
(Redirected from Camtobell)
Belotecan: A Chemotherapeutic Agent for Lung and Ovarian Cancers[edit | edit source]
Belotecan is a semi-synthetic derivative of the camptothecin family, utilized as an efficacious chemotherapy drug mainly for small cell lung cancer (SCLC) and ovarian cancer. Accredited officially in South Korea, it's commercialized under the trade name Camtobell(R).
Development and Approval[edit | edit source]
Originating from extensive chemotherapeutic research on camptothecin analogues, Belotecan was introduced to the market by ChongKunDang Pharmaceuticals, a prestigious South Korean pharmaceutical entity, in 2003[1].
Mechanism of Action[edit | edit source]
Belotecan's antineoplastic potency stems from the inhibition of the enzyme topoisomerase I. The mechanistic pathway is elucidated below:
- Targeting Topoisomerase I: Belotecan blocks topoisomerase I, exhibiting a pIC50 value of 6.56[2], an enzyme instrumental for reversible single-strand DNA breaks during replication.
- Stabilizing the Cleavable Complex: Belotecan augments the stability of the cleavable complex between topoisomerase I and DNA, hindering DNA's single-stranded break religation by the enzyme.
- Inducing Lethal DNA Breaks: The DNA replication machinery, upon encountering the stabilized complex, incurs lethal double-stranded DNA breaks, driving tumor cells towards apoptosis or programmed cell death.
Indications and Presentation[edit | edit source]
Belotecan finds its application in treating:
It is supplied in 2 mg vials designed for injection to ascertain accurate dosing and therapeutic efficacy.
Adverse Effects[edit | edit source]
Like other chemotherapeutic agents, Belotecan may trigger adverse effects like:
- Nausea
- Vomiting
- Diarrhea
- Hair loss
- Fatigue
Patient monitoring for these symptoms is crucial to ensure comfort and treatment adherence.
Conclusion[edit | edit source]
Belotecan, with its targeted action on topoisomerase I, symbolizes a stride forward in chemotherapy realms. It beckons a glimmer of hope for individuals grappling with particular cancer types. As is paramount with chemotherapy drugs, tailoring its usage to each patient's unique needs, alongside meticulous monitoring for potential adverse effects, is essential.
References[edit | edit source]
| Belotecan Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
